top of page
logo_edited.png

What we do  

Pipeline

remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients suffering from age-related neurodegenerative diseases such as Alzheimer’s and Huntington’s disease.

Pipeline

pipe_04.png

​

Alzheimer’s program 

Aims to provide symptomatic benefit and disease-modification by restoring synaptic function in diseased cells and reducing Aβ and tau pathology over time

  

Huntington’s program 

Restores cortico-striatal transmission by targeting oxidative stress

  

Discovery program

remynd’s discovery program addresses mitochondrial dysfunction, a hallmark of  Amyotrophic Lateral Sclerosis (ALS).

Get in touch

remynd is located in the Arenberg Science Park, a hub of innovation and research. Our labs and offices are situated in the Bio Incubator 3 building.

bottom of page